CNMD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide...

Stats
Today's Volume	2.60M
Average Volume	564 320
Market Cap	1.91B
EPS	$1.060 ( 2024-04-24 )
Next earnings date	( $0 ) 2024-07-24
Last Dividend	$0.200 ( 2023-12-15 )
Next Dividend	$0 ( N/A )
P/E	30.34
ATR14	$0.122 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Garner Todd W	Buy	227	Common Stock
2024-03-28	Cohen Heather L	Buy	227	Common Stock
2024-03-08	Cohen Heather L	Buy	25 000	Common Stock
2024-03-08	Cohen Heather L	Buy	27 500	Common Stock
2024-03-08	Cohen Heather L	Sell	23 847	Common Stock

INSIDER POWER
40.46
Last 96 transactions
Buy: 420 437 \| Sell: 210 624

Volume Correlation

Long: -0.35 (neutral)

Short: 0.89 (strong)

Signal:(72.182) Same movement expected

Conmed Corp Correlation

10 Most Positive Correlations
AGI	0.902
CCEP	0.902
COO	0.9
DRD	0.9
DECK	0.887
WPM	0.886
PKX	0.881
EUDG	0.88
NVO	0.877
NGG	0.873

10 Most Negative Correlations
ENIA	-0.843
DBMF	-0.841
RKLY	-0.836
LXU	-0.832
KMLM	-0.828
NIC	-0.826
GDXD	-0.821
NXQ	-0.817
DGZ	-0.817
DUST	-0.816

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Conmed Corp Correlation - Currency/Commodity

0.29
( neutral )

0.28
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.31
( neutral )

-0.07
( neutral )

Conmed Corp Financials

Annual	2023
Revenue:	$1.24B
Gross Profit:	$643.07M (51.82 %)
EPS:	$2.10

Q4	2023
Revenue:	$327.05M
Gross Profit:	$184.33M (56.36 %)
EPS:	$1.080

Q3	2023
Revenue:	$304.58M
Gross Profit:	$168.06M (55.18 %)
EPS:	$0.520

Q2	2023
Revenue:	$317.65M
Gross Profit:	$170.69M (53.73 %)
EPS:	$0.450

Financial Reports:

No articles found.

Conmed Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Conmed Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.59 - good (75.92%) | Divividend Growth Potential Score: 6.09 - Stable (21.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-03-13
Last Dividend	$0.200	2023-12-15
Next Dividend	$0	N/A
Payout Date	2024-01-05
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$9.25	--
Avg. Dividend % Per Year	0.49%	--
Score	4.23	--
Div. Sustainability Score	7.59
Div.Growth Potential Score	6.09
Div. Directional Score	6.84	--

Next Divdend (Est)
(2024-07-01)

$0.203 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

4.23

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.600	2.31%
2013	$0.650	2.32%
2014	$0.800	1.87%
2015	$0.800	1.78%
2016	$0.800	1.88%
2017	$0.800	1.81%
2018	$0.800	1.58%
2019	$0.800	1.26%
2020	$0.800	0.72%
2021	$0.800	0.72%
2022	$0.800	0.55%
2023	$0.800	0.89%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0518	1.500	8.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0280	1.200	9.07	10.00	[0 - 0.3]
returnOnEquityTTM	0.0815	1.500	-0.205	-0.308	[0.1 - 1]
payoutRatioTTM	0.380	-1.000	6.20	-6.20	[0 - 1]
currentRatioTTM	1.981	0.800	5.09	4.07	[1 - 3]
quickRatioTTM	0.858	0.800	9.66	7.73	[0.8 - 2.5]
cashRatioTTM	0.0782	1.500	-0.677	-1.015	[0.2 - 2]
debtRatioTTM	0.426	-1.500	2.90	-4.35	[0 - 0.6]
interestCoverageTTM	2.40	1.000	-0.222	-0.222	[3 - 30]
operatingCashFlowPerShareTTM	4.08	2.00	8.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.46	2.00	8.27	10.00	[0 - 20]
debtEquityRatioTTM	1.174	-1.500	5.30	-7.95	[0 - 2.5]
grossProfitMarginTTM	0.545	1.000	4.25	4.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0767	1.000	-0.466	-0.466	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.128	1.000	-0.400	-0.400	[0.2 - 2]
assetTurnoverTTM	0.541	0.800	9.73	7.78	[0.5 - 2]
Total Score				7.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	33.41	1.000	6.73	0	[1 - 100]
returnOnEquityTTM	0.0815	2.50	-0.132	-0.308	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.46	2.00	8.85	10.00	[0 - 30]
dividendYielPercentageTTM	1.143	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.08	2.00	8.64	10.00	[0 - 30]
payoutRatioTTM	0.380	1.500	6.20	-6.20	[0 - 1]
pegRatioTTM	1.482	1.500	3.46	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.101	1.000	9.98	0	[0.1 - 0.5]
Total Score				6.09

Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.